Mobile telemedicine delivery significantly enhanced HCV treatment initiation for underserved rural populations.
Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. LEWISTON — Looking back, Rosie Boyce does not recall experiencing many ...
Millions of Americans live with chronic hepatitis and may not know it, because it can take years to become symptomatic. The most common types of the virus, hepatitis B and C, can lead to liver failure ...
Hepatitis C virus treatment is increasingly being offered in primary care because medications now require less frequent monitoring and have fewer adverse effects.
CHICAGO (WLS) -- Hepatitis C cases have been rising in recent years, significantly impacting women of childbearing age. Hepatitis C can cause low birthweight, liver disorders and pre-term births in an ...
Hepatitis is an inflammation of the liver. It’s considered acute until it lasts six months, at which point it’s considered chronic. Complications that can develop from chronic hepatitis include a ...
New Delhi: According to the World Health Organization (WHO), viral hepatitis has now become as deadly as tuberculosis. Every 30 seconds, someone in the world dies of viral hepatitis. The WHO’s 2024 ...
The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA. The British drugmaker had been ...
A clinical trial has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis and treatment in hard-to-reach ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results